☰

Jogesh Mukherjee - Publications

Affiliations: 
Psychiatry and Human Behavior University of California, Irvine, Irvine, CA 
Area:
Radioligand development, Positron Emission Tomography,
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Betthauser TJ, Hillmer AT, Lao PJ, Ehlerding E, Mukherjee J, Stone CK, Christian BT. Human biodistribution and dosimetry of [(18)F]nifene, an α4β2* nicotinic acetylcholine receptor PET tracer. Nuclear Medicine and Biology. 55: 7-11. PMID 28963927 DOI: 10.1016/J.Nucmedbio.2017.08.001  0.359
2017 Mukherjee J, Lao PJ, Betthauser TJ, Samra GK, Pan ML, Patel IH, Liang C, Metherate R, Christian BT. Human Brain Imaging of Nicotinic Acetylcholine α4β2* Receptors using [(18) F]Nifene: Selectivity, Functional Activity, Toxicity, Aging Effects, Gender Effects and Extrathalamic Pathways. The Journal of Comparative Neurology. PMID 28875553 DOI: 10.1002/Cne.24320  0.369
2017 Coleman RA, Liang C, Patel R, Ali S, Mukherjee J. Brain and Brown Adipose Tissue Metabolism in Transgenic Tg2576 Mice Models of Alzheimer Disease Assessed Using (18)F-FDG PET Imaging. Molecular Imaging. 16: 1536012117704557. PMID 28654383 DOI: 10.1177/1536012117704557  0.501
2017 Lao PJ, Betthauser TJ, Tudorascu DL, Barnhart TE, Hillmer AT, Stone CK, Mukherjee J, Christian BT. [(18) F]Nifene test-retest reproducibility in first-in-human imaging of α4β2* nicotinic acetylcholine receptors. Synapse (New York, N.Y.). PMID 28420041 DOI: 10.1002/Syn.21981  0.323
2016 Mukherjee J, Majji D, Kaur J, Constantinescu CC, Narayanan TK, Shi B, Nour MT, Pan ML. PET Radiotracer Development for Imaging High-Affinity State of Dopamine D2 and D3 Receptors: Binding Studies of Fluorine-18 Labeled Aminotetralins in Rodents. Synapse (New York, N.Y.). PMID 27864853 DOI: 10.1002/Syn.21950  0.388
2016 Pithia NK, Liang C, Pan XZ, Pan ML, Mukherjee J. Synthesis and evaluation of (S)-[(18)F]fesetron in the rat brain as a potential PET imaging agent for serotonin 5-HT3 receptors. Bioorganic & Medicinal Chemistry Letters. PMID 26979158 DOI: 10.1016/j.bmcl.2016.03.018  0.345
2015 Mukherjee J, Bajwa AK, Wooten DW, Hillmer AT, Pan ML, Pandey SK, Saigal N, Christian BT. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species- rodents, nonhuman primates, and humans¶. The Journal of Comparative Neurology. PMID 26509362 DOI: 10.1002/Cne.23919  0.386
2015 Mukherjee J, Constantinescu CC, Hoang AT, Jerjian T, Majji D, Pan ML. Dopamine D3 receptor binding of (18) F-fallypride: Evaluation using in vitro and in vivo PET imaging studies. Synapse (New York, N.Y.). 69: 577-91. PMID 26422464 DOI: 10.1002/Syn.21867  0.397
2015 Baranwal A, Mukherjee J. (18)F-Fluorodeoxyglucamines: Reductive amination of hydrophilic (18)F-fluoro-2-deoxyglucose with lipophilic amines for the development of potential PET imaging agents. Bioorganic & Medicinal Chemistry Letters. 25: 2902-6. PMID 26048782 DOI: 10.1016/j.bmcl.2015.05.053  0.422
2015 Mirbolooki MR, Schade KN, Constantinescu CC, Pan ML, Mukherjee J. Enhancement of 18F-fluorodeoxyglucose metabolism in rat brain frontal cortex using a β3 adrenoceptor agonist. Synapse (New York, N.Y.). 69: 96-8. PMID 25347981 DOI: 10.1002/Syn.21789  0.308
2014 Hillmer AT, Wooten DW, Bajwa AK, Higgins AT, Lao PJ, Betthauser TJ, Barnhart TE, Rowley HA, Stone CK, Johnson SC, Mukherjee J, Christian BT. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1973-9. PMID 25453045 DOI: 10.2967/Jnumed.114.145151  0.329
2014 Kaur J, Khararjian A, Coleman RA, Constantinescu CC, Pan ML, Mukherjee J. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride. Nuclear Medicine and Biology. 41: 841-7. PMID 25199843 DOI: 10.1016/J.Nucmedbio.2014.08.002  0.433
2014 Wooten DW, Hillmer AT, Murali D, Barnhart TE, Thio JP, Bajwa AK, Bonab AA, Normandin MD, Schneider ML, Mukherjee J, Christian BT. Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway. American Journal of Nuclear Medicine and Molecular Imaging. 4: 483-9. PMID 25143866  0.406
2014 Kuruvilla SA, Hillmer AT, Wooten DW, Patel A, Christian BT, Mukherjee J. Synthesis and evaluation of 2-(18)F-fluoro-5-iodo-3-[2-(S)-3,4-dehydropyrrolinylmethoxy]pyridine ((18)F-Niofene) as a potential imaging agent for nicotinic α4β2 receptors. American Journal of Nuclear Medicine and Molecular Imaging. 4: 354-64. PMID 24982821  0.419
2014 Tang W, Kuruvilla SA, Galitovskiy V, Pan ML, Grando SA, Mukherjee J. Targeting histone deacetylase in lung cancer for early diagnosis: (18)F-FAHA PET/CT imaging of NNK-treated A/J mice model. American Journal of Nuclear Medicine and Molecular Imaging. 4: 324-32. PMID 24982818  0.304
2014 Garcia A, Venugopal A, Pan ML, Mukherjee J. Imaging pancreas in healthy and diabetic rodent model using [18F]fallypride positron emission tomography/computed tomography. Diabetes Technology & Therapeutics. 16: 640-3. PMID 24828096 DOI: 10.1089/Dia.2014.0041  0.522
2014 Pandey SK, Kaur J, Easwaramoorthy B, Shah A, Coleman R, Mukherjee J. Multimodality imaging probe for positron emission tomography and fluorescence imaging studies. Molecular Imaging. 13: 1-7. PMID 24824856 DOI: 10.2310/7290.2014.00005  0.446
2014 Pandey S, Venugopal A, Kant R, Coleman R, Mukherjee J. ¹²⁴I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors. Nuclear Medicine and Biology. 41: 426-31. PMID 24602412 DOI: 10.1016/J.Nucmedbio.2014.01.011  0.462
2014 Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, Tahara A, Constantinescu CC, Zhou J, Boersma HH, Imaizumi T, Nakano M, Finn A, Fayad Z, Virmani R, et al. 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nature Medicine. 20: 215-9. PMID 24412923 DOI: 10.1038/Nm.3437  0.367
2014 Baranwal A, Patel HH, Mukherjee J. 18F-Fluorodeoxyglycosylamines: Maillard reaction of 18F-fluorodeoxyglucose with biological amines. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 86-91. PMID 24327460 DOI: 10.1002/jlcr.3168  0.372
2014 Mirbolooki MR, Upadhyay SK, Constantinescu CC, Pan ML, Mukherjee J. Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹⁸F]FDG PET/CT study in mice. Nuclear Medicine and Biology. 41: 10-6. PMID 24090673 DOI: 10.1016/J.Nucmedbio.2013.08.009  0.329
2013 Hillmer AT, Wooten DW, Slesarev MS, Ahlers EO, Barnhart TE, Schneider ML, Mukherjee J, Christian BT. Measuring α4β2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1806-14. PMID 23942367 DOI: 10.1038/Jcbfm.2013.136  0.367
2013 Hillmer AT, Wooten DW, Farhoud M, Higgins AT, Lao PJ, Barnhart TE, Mukherjee J, Christian BT. PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding. Synapse (New York, N.Y.). 67: 882-6. PMID 23913347 DOI: 10.1002/Syn.21698  0.341
2013 Pithia N, Gulati N, Pandey S, Coleman R, Kant R, Mukherjee J. Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging. Nuclear Medicine and Biology. 40: 697-704. PMID 23562464 DOI: 10.1016/J.Nucmedbio.2013.02.011  0.547
2013 Wooten DW, Hillmer AT, Moirano JM, Tudorascu DL, Ahlers EO, Slesarev MS, Barnhart TE, Mukherjee J, Schneider ML, Christian BT. 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate. Neuroimage. 77: 125-32. PMID 23537936 DOI: 10.1016/J.Neuroimage.2013.03.027  0.307
2013 Saigal N, Bajwa AK, Faheem SS, Coleman RA, Pandey SK, Constantinescu CC, Fong V, Mukherjee J. Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET. Synapse (New York, N.Y.). 67: 596-608. PMID 23504990 DOI: 10.1002/Syn.21665  0.534
2013 Hillmer AT, Wooten DW, Farhoud M, Barnhart TE, Mukherjee J, Christian BT. The effects of lobeline on α4β2* nicotinic acetylcholine receptor binding and uptake of [(18)F]nifene in rats. Journal of Neuroscience Methods. 214: 163-9. PMID 23370310 DOI: 10.1016/J.Jneumeth.2013.01.018  0.355
2013 Constantinescu CC, Garcia A, Mirbolooki MR, Pan ML, Mukherjee J. Evaluation of [18F]Nifene biodistribution and dosimetry based on whole-body PET imaging of mice. Nuclear Medicine and Biology. 40: 289-94. PMID 23265670 DOI: 10.1016/J.Nucmedbio.2012.11.004  0.524
2013 Pichika R, Kuruvilla SA, Patel N, Vu K, Sinha S, Easwaramoorthy B, Narayanan TK, Shi B, Christian B, Mukherjee J. Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET. Nuclear Medicine and Biology. 40: 117-25. PMID 23141552 DOI: 10.1016/J.Nucmedbio.2012.09.009  0.39
2013 Mirbolooki MR, Constantinescu CC, Pan ML, Mukherjee J. Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity. Synapse (New York, N.Y.). 67: 79-93. PMID 23080264 DOI: 10.1002/Syn.21617  0.338
2013 Constantinescu CC, Sevrioukov E, Garcia A, Pan ML, Mukherjee J. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 222-9. PMID 22833323 DOI: 10.1007/S11307-012-0582-Y  0.528
2012 Hillmer AT, Wooten DW, Slesarev MS, Ahlers EO, Barnhart TE, Murali D, Schneider ML, Mukherjee J, Christian BT. PET imaging of α4β2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1471-80. PMID 22851633 DOI: 10.2967/Jnumed.112.103846  0.37
2012 Bieszczad KM, Kant R, Constantinescu CC, Pandey SK, Kawai HD, Metherate R, Weinberger NM, Mukherjee J. Nicotinic acetylcholine receptors in rat forebrain that bind ¹⁸F-nifene: relating PET imaging, autoradiography, and behavior. Synapse (New York, N.Y.). 66: 418-34. PMID 22213342 DOI: 10.1002/Syn.21530  0.323
2011 Mirbolooki MR, Constantinescu CC, Pan ML, Mukherjee J. Quantitative assessment of brown adipose tissue metabolic activity and volume using 18F-FDG PET/CT and β3-adrenergic receptor activation. Ejnmmi Research. 1: 30. PMID 22214183 DOI: 10.1186/2191-219X-1-30  0.36
2011 Kant R, Constantinescu CC, Parekh P, Pandey SK, Pan ML, Easwaramoorthy B, Mukherjee J. Evaluation of F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging. Ejnmmi Research. 1. PMID 22039577 DOI: 10.1186/2191-219X-1-6  0.372
2011 McLarty K, Moran MD, Scollard DA, Chan C, Sabha N, Mukherjee J, Guha A, McLaurin J, Nitz M, Houle S, Wilson AA, Reilly RM, Vasdev N. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice. Nuclear Medicine and Biology. 38: 953-9. PMID 21982567 DOI: 10.1016/J.Nucmedbio.2011.02.017  0.37
2011 Pichika R, Easwaramoorthy B, Christian BT, Shi B, Narayanan TK, Collins D, Mukherjee J. Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine). Nuclear Medicine and Biology. 38: 1183-92. PMID 21831652 DOI: 10.1016/J.Nucmedbio.2011.05.005  0.391
2011 Wooten D, Hillmer A, Murali D, Barnhart T, Schneider ML, Mukherjee J, Christian BT. An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate. Nuclear Medicine and Biology. 38: 925-32. PMID 21741252 DOI: 10.1016/J.Nucmedbio.2011.04.001  0.337
2011 Garcia A, Mirbolooki MR, Constantinescu C, Pan ML, Sevrioukov E, Milne N, Wang PH, Lakey J, Chandy KG, Mukherjee J. 18F-Fallypride PET of pancreatic islets: in vitro and in vivo rodent studies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1125-32. PMID 21680697 DOI: 10.2967/Jnumed.111.088583  0.572
2011 Hillmer AT, Wooten DW, Moirano JM, Slesarev M, Barnhart TE, Engle JW, Nickles RJ, Murali D, Schneider ML, Mukherjee J, Christian BT. Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey. Synapse (New York, N.Y.). 65: 1309-18. PMID 21674627 DOI: 10.1002/Syn.20965  0.383
2011 Wooten DW, Moraino JD, Hillmer AT, Engle JW, Dejesus OJ, Murali D, Barnhart TE, Nickles RJ, Davidson RJ, Schneider ML, Mukherjee J, Christian BT. In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate. Synapse (New York, N.Y.). 65: 592-600. PMID 21484878 DOI: 10.1002/Syn.20878  0.347
2011 Constantinescu CC, Coleman RA, Pan ML, Mukherjee J. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride. Synapse (New York, N.Y.). 65: 778-87. PMID 21218455 DOI: 10.1002/Syn.20904  0.558
2010 Vu?kovi? MG, Li Q, Fisher B, Nacca A, Leahy RM, Walsh JP, Mukherjee J, Williams C, Jakowec MW, Petzinger GM. Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in vivo imaging with [¹⁸F]fallypride. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2777-84. PMID 20960487 DOI: 10.1002/Mds.23407  0.364
2010 Nguyen VL, Pichika R, Bhakta PH, Kant R, Mukherjee J. (R)-N-Methyl-3-(3'-[F]fluoropropyl)phenoxy)-3-phenylpropanamine (F-MFP3) as a potential PET imaging agent for norepinephrine transporter. Journal of Labelled Compounds & Radiopharmaceuticals. 53: 172-177. PMID 20495670 DOI: 10.1002/Jlcr.1744  0.371
2010 Vandehey NT, Moirano JM, Converse AK, Holden JE, Mukherjee J, Murali D, Nickles RJ, Davidson RJ, Schneider ML, Christian BT. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 994-1007. PMID 20040928 DOI: 10.1038/Jcbfm.2009.270  0.416
2010 Wooten D, Hillmer A, Moirano J, Tudorascu D, Murali D, Barnhart T, Kalin N, Davidson R, Mukherjee J, Schneider M, Christian B. 5-HT1A binding of [18F]MEFWAY in the rhesus monkey Neuroimage. 52: S129-S130. DOI: 10.1016/J.Neuroimage.2010.04.105  0.31
2008 Easwaramoorthy B, Coleman R, Constantinescu C, Pan M-, Mukherjee J. 18F-Nifene for quantification of α4β2 nicotinic receptors Neuroimage. 41. DOI: 10.1016/J.Neuroimage.2008.04.148  0.524
2008 Saigal N, Faheem S, Coleman R, Constantinescu C, Mukherjee J. Rodent study of [18F]-mefway using microPET Neuroimage. 41. DOI: 10.1016/J.Neuroimage.2008.04.132  0.561
2008 Constantinescu C, Coleman R, Pan M-, Mukherjee J. Dynamic imaging of brain D2/3 receptors with 18F-Fallypride in rodents using inveon MicroPET Neuroimage. 41. DOI: 10.1016/J.Neuroimage.2008.04.094  0.559
2008 Wang CS, Head E, Tsu W, Doshi A, Vasilevko V, Coleman R, Constantinescu C, Saigal N, Pan M-, Mukherjee J. Evaluation of 18F-FBM for imaging β-amyloid plaques and neurofibrillary tangles Neuroimage. 41. DOI: 10.1016/J.Neuroimage.2008.04.088  0.529
2008 Patel PC, Sarsoza F, Vasilevko V, Pan M-, Tsu W, Constantinescu C, Coleman R, Head E, Mukherjee J. 18F-fluoropropyl curcumin binding to β-amyloid plaques in transgenic mouse model of Alzheimer's disease Neuroimage. 41. DOI: 10.1016/J.Neuroimage.2008.04.083  0.498
2007 Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. Synapse (New York, N.Y.). 61: 29-36. PMID 17068780 DOI: 10.1002/syn.20338  0.344
2006 Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 1697-706. PMID 17015907  0.395
2006 Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nuclear Medicine and Biology. 33: 295-304. PMID 16631077 DOI: 10.1016/j.nucmedbio.2005.12.017  0.387
2005 Mukherjee J, Christian BT, Narayanan TK, Shi B, Collins D. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET. Brain Research. 1032: 77-84. PMID 15680944 DOI: 10.1016/j.brainres.2004.11.005  0.324
2005 Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 130-40. PMID 15632043  0.345
2004 Shi B, Narayanan TK, Christian BT, Chattopadhyay S, Mukherjee J. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5′-18F- fluoropentyl)aminotetralin (18F-5-OH-FPPAT) in rodents and nonhuman primates Nuclear Medicine and Biology. 31: 303-311. PMID 15028242 DOI: 10.1016/j.nucmedbio.2003.10.004  0.362
2002 Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, Mantil J. Brain imaging of 18F-fallypride in normal volunteers: Blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors Synapse. 46: 170-188. PMID 12325044 DOI: 10.1002/syn.10128  0.37
2000 Mukherjee J, Christian BT, Narayanan TK, Shi B, Mantil J. Measurement of striatal and extrastriatal D-2 receptor occupancy by clozapine and risperidone using [18F]fallypride and PET Neuroimage. 11: S53.  0.361
1999 Mukherjee J, Yang ZY. Development of N-[3-(2',4'-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A Nuclear Medicine and Biology. 26: 619-625. PMID 10587099 DOI: 10.1016/S0969-8051(99)00027-X  0.371
1999 Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride Nuclear Medicine and Biology. 26: 519-527. PMID 10473190 DOI: 10.1016/S0969-8051(99)00012-8  0.368
1999 Mukherjee J, Yang ZY, Lew R. N-(6-18F-fluorohexyl)-N-methylpropargylamine: A fluorine-18-labeled monoamine oxiduse B inhibitor for potential use in PET studies Nuclear Medicine and Biology. 26: 111-116. PMID 10096510 DOI: 10.1016/S0969-8051(98)00061-4  0.345
1998 Mukherjee J, Das MK, Yang ZY, Lew R. Evaluation of the binding of the radiolabeled antidepressant drug, 18F-fluoxetine in the rodent brain: An in vitro and in vivo study Nuclear Medicine and Biology. 25: 605-610. PMID 9804041 DOI: 10.1016/S0969-8051(98)00043-2  0.324
1997 Mukherjee J, Yang ZY, Lew R, Brown T, Kronmal S, Cooper MD, Seiden LS. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography. Synapse (New York, N.Y.). 27: 1-13. PMID 9268060 DOI: 10.1002/(SICI)1098-2396(199709)27:1<1::AID-SYN1>3.0.CO;2-9  0.369
1996 Yang ZY, Perry B, Mukherjee J. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors Nuclear Medicine and Biology. 23: 793-805. PMID 8940723 DOI: 10.1016/0969-8051(96)00076-5  0.326
1996 Mukherjee J, Yang ZY, Brown T, Roemer J, Cooper M. 18F-desmethoxyfallypride: A fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for pet imaging studies of dopamine D2 receptors Life Sciences. 59: 669-678. PMID 8761017 DOI: 10.1016/0024-3205(96)00348-7  0.385
1995 Mukherjee J, Yang ZY, Das MK, Brown T. Fluorinated benzamide neuroleptics-III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer Nuclear Medicine and Biology. 22: 283-296. PMID 7627142 DOI: 10.1016/0969-8051(94)00117-3  0.347
1993 Mukherjee J, Das MK, Yang Z, Yasillo NJ, Kronmal S, Brown T, Cooper M. COMPARISON OF [F-18]FALLYPRIDE AND [F-18]FPMB AS HIGH AFFINITY PET RADIOTRACERS FOR DOPAMINE D-2 RECEPTORS Clinical Nuclear Medicine. 18: 919. DOI: 10.1097/00003072-199310000-00030  0.39
1990 Mukherjee J, Perry BD, Cooper M. Fluorinated benzamide neuroleptics. 1. Radiosynthesis of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(2[F-18]fluoroethyl)-2-methoxybenzamide: A potential fluorine-18 labeled PET radiotracer for dopamine D2 receptors Journal of Labelled Compounds and Radiopharmaceuticals. 28: 609-616. DOI: 10.1002/JLCR.2580280511  0.327
Show low-probability matches.